Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹13,980 Cr₹11,516 Cr₹10,728 Cr₹9,620 Cr₹8,508 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹13,980 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹13,980 Cr
Mar2025₹11,516 Cr
Mar2024₹10,728 Cr
Mar2023₹9,620 Cr
Mar2022₹8,508 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹13,980 Cr
21.39
Mar2025 ₹11,516 Cr
7.35
Mar2024 ₹10,728 Cr
11.51
Mar2023 ₹9,620 Cr
13.07
Mar2022 ₹8,508 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹182,753.7 Cr -3.4% -4.2% 37.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics
MANKIND PHARMA ₹95,743.9 Cr 1.8% -3.1% -11% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-3.4%

-4.2%

37.1%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses